Anti-ischemic properties of metabolic drugs in the experiment
In this article the comparative characteristic efficacy of medicines basic therapy of coronary heart disease and metabolic drugs action in experimental myocardial infarction. The studies established pathogenetic orientation metabolic efficiency means and expediency and necessity of their treatment-and-prophylactic use in cardiovascular diseases